← Leaderboards
Neil Sidell
Emory University
$6,718,774
Attributed
$7,575,496
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $937.8K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$7,575,496 · 9
By mechanism
R01$4,557,021 · 3
U01$1,911,408 · 2
P01$456,817 · 1
R21$398,250 · 1
R03$152,000 · 1
R41$100,000 · 1
Top collaborators
- Winston E Thompson6 shared
- Ruo-Pan Huang1 shared
Most similar at Emory University
Same institution · by research overlap
- H. Criss Hartzell$12,440,886
- Douglas C Wallace$28,541,550
- Sampath Parthasarathy$11,379,014
- Todd M Preuss$3,447,225
- Friedrich Alfred Wieser$418,500
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsEstrogensTissuesWomanEndometriosisEndometrialLesionGrowthPublic Health Medicine (Field)Mouse ModelLeadPropertyMethodologyRegulationPhenotypeStromal CellsSignal TransductionApoptosisIn VivoReportingAffectMediatingEndometriumAromatase
Grant awards (30)
1/2-Atlanta Center for Translational Research in Endometriosis (ACTRE)$277,045
U01 · FY2014 · HD · contact PI
2/2-Atlanta Center for Translational Research in Endometriosis (ACTRE)$252,913
U01 · FY2014 · HD
1/2-Atlanta Center for Translational Research in Endometriosis (ACTRE)$273,139
U01 · FY2013 · HD · contact PI
2/2-Atlanta Center for Translational Research in Endometriosis (ACTRE)$249,353
U01 · FY2013 · HD
Retinoid effects on inflammation and cell growth associated with endometriosis$331,452
R01 · FY2012 · HD · contact PI
1/2-Atlanta Center for Translational Research in Endometriosis (ACTRE)$290,641
U01 · FY2012 · HD · contact PI
2/2-Atlanta Center for Translational Research in Endometriosis (ACTRE)$270,354
U01 · FY2012 · HD
Retinoid effects on inflammation and cell growth associated with endometriosis$331,452
R01 · FY2011 · HD · contact PI
Development and Testing of ERE-Targeting Molecules for Breast Cancer Therapy$308,434
R01 · FY2011 · CA · contact PI
1/2-Atlanta Center for Translational Research in Endometriosis (ACTRE)$297,963
U01 · FY2011 · HD · contact PI
Retinoid effects on inflammation and cell growth associated with endometriosis$345,263
R01 · FY2010 · HD · contact PI
Development and Testing of ERE-Targeting Molecules for Breast Cancer Therapy$317,973
R01 · FY2010 · CA · contact PI
Retinoid effects on inflammation and cell growth associated with endometriosis$155,873
R01 · FY2010 · HD · contact PI
Biosignature of the endometrium in women with endometriosis$100,000
R41 · FY2010 · HD
Retinoid effects on inflammation and cell growth associated with endometriosis$348,750
R01 · FY2009 · HD · contact PI
Development and Testing of ERE-Targeting Molecules for Breast Cancer Therapy$317,973
R01 · FY2009 · CA · contact PI
Development of Nuclear Antioxidants for the Treatment of Endometriosis$192,000
R21 · FY2009 · HD · contact PI
Retinoid effects on inflammation and cell growth associated with endometriosis$348,188
R01 · FY2008 · HD · contact PI
Development and Testing of ERE-Targeting Molecules for Breast Cancer Therapy$331,429
R01 · FY2008 · CA · contact PI
Development of Nuclear Antioxidants for the Treatment of Endometriosis$206,250
R21 · FY2008 · HD · contact PI
PHENYLACETATE--NOVEL THERAPEUTIC USES IN BREAST CANCER$283,860
R01 · FY2005 · CA
PHENYLACETATE--NOVEL THERAPEUTIC USES IN BREAST CANCER$283,860
R01 · FY2004 · CA
PHENYLACETATE--NOVEL THERAPEUTIC USES IN BREAST CANCER$283,860
R01 · FY2003 · CA
DOES PKU PROTECT AGAINST CANCER?$76,000
R03 · FY2003 · HD
PHENYLACETATE--NOVEL THERAPEUTIC USES IN BREAST CANCER$283,860
R01 · FY2002 · CA
HORMONAL REGULATION OF INFLAMMATORY RESPONSES &CELL GROWTH IN ENDOMETRIOSIS$165,355
P01 · FY2002 · HD
DOES PKU PROTECT AGAINST CANCER?$76,000
R03 · FY2002 · HD
PHENYLACETATE--NOVEL THERAPEUTIC USES IN BREAST CANCER$284,794
R01 · FY2001 · CA
HORMONAL REGULATION OF INFLAMMATORY RESPONSES &CELL GROWTH IN ENDOMETRIOSIS$165,355
P01 · FY2001 · HD
HORMONAL REGULATION OF INFLAMMATORY RESPONSES &CELL GROWTH IN ENDOMETRIOSIS$126,107
P01 · FY2000 · HD